Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.
Clinical trial NCT03158688 · COMPLETED
Trial details
- NCT number
- NCT03158688
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-13
- Primary completion
- 2019-07-14
- Enrollment
- 466
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.